- Home
- ACLX vs CBT Comparison
ACLX vs CBT Comparison
Compare ACLX & CBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACLX
- CBT
- Stock Information
- Founded
- ACLX 2015
- CBT 2019
- Country
- ACLX United States
- CBT United States
- Employees
- ACLX N/A
- CBT N/A
- Industry
- ACLX Biotechnology: Pharmaceutical Preparations
- CBT Major Chemicals
- Sector
- ACLX Health Care
- CBT Industrials
- Exchange
- ACLX Nasdaq
- CBT Nasdaq
- Market Cap
- ACLX 4.4B
- CBT 4.0B
- IPO Year
- ACLX 2022
- CBT N/A
- Fundamental
- Price
- ACLX $90.01
- CBT $61.37
- Analyst Decision
- ACLX Strong Buy
- CBT Hold
- Analyst Count
- ACLX 8
- CBT 3
- Target Price
- ACLX $115.50
- CBT $79.33
- AVG Volume (30 Days)
- ACLX 427.8K
- CBT 488.1K
- Earning Date
- ACLX 11-05-2025
- CBT 11-03-2025
- Dividend Yield
- ACLX N/A
- CBT 2.92%
- EPS Growth
- ACLX N/A
- CBT N/A
- EPS
- ACLX N/A
- CBT 6.02
- Revenue
- ACLX $35,898,000.00
- CBT $3,713,000,000.00
- Revenue This Year
- ACLX N/A
- CBT $6.09
- Revenue Next Year
- ACLX $220.95
- CBT $3.05
- P/E Ratio
- ACLX N/A
- CBT $10.23
- Revenue Growth
- ACLX N/A
- CBT N/A
- 52 Week Low
- ACLX $47.86
- CBT $58.99
- 52 Week High
- ACLX $100.34
- CBT $115.16
- Technical
- Relative Strength Index (RSI)
- ACLX 57.21
- CBT 29.02
- Support Level
- ACLX $85.00
- CBT $60.03
- Resistance Level
- ACLX $91.68
- CBT $62.57
- Average True Range (ATR)
- ACLX 4.14
- CBT 1.94
- MACD
- ACLX -0.08
- CBT -0.10
- Stochastic Oscillator
- ACLX 71.76
- CBT 19.90
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.
About CBT Cabot Corporation
Cabot Corp manufactures and sells a variety of chemicals, materials, and chemical-based products. The company organizes itself into the following operating segments based on the product type; the Reinforcement Materials segment which generates maximum revenue provides reinforcing carbon products used in tires, and industrial products such as hoses, belts, extruded profiles, and molded goods; and the Performance Chemicals segment aggregates the specialty carbons, specialty compounds, fumed metal oxides, battery materials, inkjet colorants, and aerogel product lines. Geographically, the company derives maximum revenue from its customers in Europe, the Middle East, and Africa and the rest from the Americas and Asia Pacific region.